Clinical WP

This project will focus on long-term follow-up of patients after completion of the clinical study and will be done through the EuMCLNetwork registry allowing a comparison of different sequential treatments. Main focus will be validating clinical and biological prognosticators (MIPI, MIPI-C, etc) and characterize relapse patterns and salvage treatment in the first line BTKi era.

The biostatistical core unit will support the analyses of WP II and III to identify clinical correlations of distinct altered signal pathways.